Illumina (NASDAQ:ILMN) Declares Sharp Boost in Fiscal Fourth Quarter Profit on Business Unit Sale

Illumina, Inc (NASDAQ:ILMN) announced a sharp boost in fiscal Q4 profit on Monday after the sale of a business unit to Amgen, Inc (NASDAQ:AMGN).

Genetic analysis Instrument Company booked a $48.6 million gain from the pre-tax sale of its stake in deCode Genetics Inc during the quarter.

The San Diego, California based Illumina reported that its net income moved up to $72 million or 53 cents a share in the three months period that finished Dec 30 from $11.7 million or 9 cents a share in the similar quarter a year ago. Revenue moved up 24% to $309.3 million.

The corporation earned 57 million or 42 cents a share without special gains and costs.

Shifting reader’s focus to broader market, let us consider market performance of other stocks that significantly affect same sector. Affymetrix, Inc. (NASDAQ:AFFX) fell -3.05% to settle at $3.81, PerkinElmer, Inc. (NYSE:PKI) moved down -0.79% to end at $35.38 while Sequenom, Inc. (NASDAQ:SQNM) jumped +5.28% to finish at $4.59 on Monday.

Illumina, Inc. (NASDAQ:ILMN) on Jan 28, 2013 decreased -0.85% to the closing price of $51.62. The overall volume in the last trading session was 1.75 million shares. Its fifty two weeks range was $37.77 – $57.00. The total market capitalization remained at $6.37 billion.

ILMN is ahead of its 52-week low with 36.67% and lagging behind from its 52-week high price with -9.44%. ILMN’s last month’s stock price volatility remained 2.68%. In its share capital ILMN has 123.38 million outstanding shares, among them 121.65 million shares have been floated in market exchange. ILMN’s stock’s insider ownership remained 1.28%.

The stock price of ILMN is moving down from its 20 days moving average with -2.18% and remote negatively from 50 days moving average with -1.36%. ILMN’s current year’s earnings per share experienced a downfall of -28.39% while its current quarter performance remained at 14.23%. Company’s beta coefficient included 0.59. Beta factors measure the amount of market risk associated with market trade.

DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with! CLICK HERE TO START YOUR FREE 30-DAY TRIAL

This entry was posted in Main Post, Technology and tagged , , , , , , , , , , , . Bookmark the permalink.